AMICUS THERAPEUTICS, INC. (FOLD) has 351 open-market insider trades by 44 insiders since 2007. The most active filer is John F. Crowley, Chairman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Glaxosmithkline PLC | — | — | 3 | $81.4M | 2014-10-27 |
| John F. Crowley | Chairman | — | 94 | $39.6M | 2024-03-01 |
| Perceptive Advisors LLC | 10% Owner | — | 6 | $36.9M | 2018-09-13 |
| Perceptive LIFE Sciences Master FUND Ltd. via Joseph Edelman | 10% Owner | — | 7 | $36.0M | 2018-09-21 |
| James N. Topper | Dir10% | — | 38 | $34.0M | 2008-03-10 |
| Hung Do | CSO | — | 17 | $11.1M | 2021-04-06 |
| Jay Barth | — | — | 21 | $9.8M | 2020-09-30 |
| Joseph Edelman | 10% Owner | — | 4 | $9.4M | 2018-10-03 |
| Bradley L. Campbell | CEOPres | — | 39 | $8.1M | 2026-03-02 |
| Mark W. Perry | 10% | — | 2 | $6.6M | 2012-03-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Bradley L. Campbell | President | Sell | $323K | 2026-03-02 |
| Bradley L. Campbell | CEO & President | Sell | $1.1M | 2026-01-20 |
| David Michael Clark | CPO | Sell | $727K | 2025-12-19 |
| Bradley L. Campbell | CEO & President | Sell | $1.7M | 2025-12-15 |
| David Michael Clark | CPO | Sell | $282K | 2025-12-15 |
| Bradley L. Campbell | CEO & President | Sell | $292K |
Companies that share insiders with FOLD, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-12-01 |
| Ellen Rosenberg | CLO | Sell | $958K | 2025-11-24 |
| David Michael Clark | CPO | Sell | $518K | 2025-11-24 |
| Jeff Castelli | — | Sell | $1.5M | 2025-11-24 |
| Bradley L. Campbell | CEO & President | Sell | $293K | 2025-11-24 |
| David Michael Clark | CPO | Sell | $488K | 2025-11-04 |
| Bradley L. Campbell | President | Sell | $4K | 2025-02-19 |
| Bradley L. Campbell | CEO & President | Sell | $75K | 2024-12-02 |
| Bradley L. Campbell | CEO & President | Sell | $198K | 2024-11-06 |
| Bradley L. Campbell | CEO & President | Sell | $86K | 2024-11-01 |